Dr. Ian Lewis, Novartis Pharmaceuticals, CH
| Start Date | 02.12.2014 - 17:00 |
| Event End | 02.12.2014 - 18:30 |
| Location | Universität Zürich, Campus Irchel, Departement für Chemie |
«SOM230: A new therapeutic modality for Cushing’s disease»
| Start Date | 02.12.2014 - 17:00 |
| Event End | 02.12.2014 - 18:30 |
| Location | Universität Zürich, Campus Irchel, Departement für Chemie |
«SOM230: A new therapeutic modality for Cushing’s disease»